v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and Cash Equivalent $ 57,902 $ 137,564
Restricted cash 33,184 3,439
Accounts receivable, net 37,887 51,563
Inventory, net 98,666 83,343
Lease Liability 135,536  
Prepaid expenses 11,725 16,120
Other current assets 19,909 2,228
Total current assets 259,273 294,257
Non-current assets:    
Property and equipment, net1 327,192 344,846
Right-or-use assets - operating, net 86,773 95,846
Right-of-use assets - finance, net 12,947 14,811
Intangible assets, net1 275,342 293,994
Goodwill 208,173 283,484
Deferred tax asset 13,501 13,127
Other non-current assets 14,099 14,990
Total non-current assets 938,027 1,061,098
TOTAL ASSETS 1,197,300 1,355,355
Current liabilities:    
Accounts payable 16,540 13,651
Accrued liabilities 58,017 54,296
Short-term borrowings 10,784 11,934
Income taxes payable 0 348
Less: current lease liabilities 9,793 9,629
Less: current lease liabilities 2,480 1,994
Deferred and contingent consideration, short-term 2,566 2,486
Total current liabilities 100,180 94,338
Non-current liabilities:    
Long-term notes and loans payable, net 417,095 460,750
Operating lease liabilities 125,743 135,273
Finance lease liabilities 18,269 20,061
Deferred tax liability 33,619 38,950
Deferred and contingent consideration, long-term 5,815 7,736
Tax receivable agreement liability 71,603 79,457
Uncertain tax position liability 171,474 122,468
Other long-term liabilities 1,000 8,146
Total non-current liabilities 844,618 872,841
TOTAL LIABILITIES 944,798 967,179
COMMITMENTS AND CONTINGENCIES (Note 15)
SHAREHOLDERS’ EQUITY    
Share capital 1,722,277 1,706,822
Additional paid-in-capital 120,047 122,750
Accumulated other comprehensive loss (1,631) (2,232)
Accumulated deficit (1,500,244) (1,352,486)
Equity of Cresco Labs Inc. 340,449 474,854
Non-controlling interests (87,947) (86,678)
TOTAL SHAREHOLDERS’ EQUITY 252,502 388,176
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 1,197,300 $ 1,355,355